Global Drug Delivery Devices Market to Reach USD 200,627.30 Million by 2031 | CAGR of 6.3%

Based on type, the market is segmented into Injectable Devices, Inhalation Devices, Implantable Devices, Transdermal Devices, Oral Devices, and Others.

• The injectable devices segment accounted for the largest market share in 2023, driven by their efficiency in precise drug delivery and rapid onset of action. Products like syringes, autoinjectors, and pen injectors are widely adopted for chronic disease management and biologic therapies.
• The transdermal devices segment is projected to grow at the fastest CAGR during the forecast period, supported by the rising preference for non-invasive drug administration methods, including patches and microneedle-based devices.

Based on end-user, the market is categorized into Hospitals, Clinics, Home Care Settings, Ambulatory Surgical Centers, and Others.

• The hospitals segment dominated the market in 2023 with a 48.18% share, driven by high adoption of advanced drug delivery devices for critical care and patient management. Devices such as infusion pumps, inhalers, and implantable systems are essential in hospital settings.
• The home care settings segment is expected to register the highest CAGR, fueled by the growing trend of at-home care and the adoption of wearable and portable drug delivery solutions for chronic disease management.

Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

• North America: Held the largest market share in 2023 at 44.31%, valued at USD 54,749.44 million, attributed to robust healthcare infrastructure and advancements in drug delivery technologies.
• Asia-Pacific: Expected to grow at the fastest CAGR of 7.7%, driven by increasing healthcare expenditure, a large aging population, and advancements in smart drug delivery systems.